Peter A. Pinto, M.D.

Peter A. Pinto, M.D.
Investigator
Urologic Oncology Branch
Head, Prostate Cancer Section

Dr. Pinto is an Investigator and faculty member in the Urologic Oncology Branch of the National Cancer Institute, National Institutes of Health in Bethesda, Md. Following a residency in Urologic Surgery at Long Island Jewish Medical Center - Albert Einstein College of Medicine in New York, he was a Fellow and Clinical Instructor at the Brady Urologic Institute, Johns Hopkins Hospital. Dr. Pinto is a Board Certified Urologic Surgeon specializing in oncology and is the Director of the Urologic Oncology Fellowship Program at the National Cancer Institute. He is nationally and internationally recognized as an expert in the minimally invasive treatment of urologic cancers, specializing in laparoscopic and robotic surgery for prostate, kidney, bladder, and testicular cancer.

Areas of Expertise
urologic cancers, laparoscopy, robotic surgery

Contact Info

Peter A. Pinto, M.D.
Center for Cancer Research
National Cancer Institute
Building 10, Hatfield CRC, Room 2W-5940
Bethesda, MD 20892
Ph: 301-496-6353
pintop@mail.nih.gov
Permalink

Dr. Pinto’s scientific mission is development of novel diagnostic and treatment modalities for localized and locally advanced prostate cancer.

Research efforts are centered on investigation of multiparametric MRI (mpMRI) in prostate cancer to improve diagnosis with mpMRI whole-mount pathology correlation and creation of a tumor-directed biopsy device; development of image-guided focal prostate cancer therapy; and evaluation of immunotherapy, molecular targeted therapy or other pharmacotherapies in the management of localized or locally advanced prostate cancer.

 

Scientific Focus Areas:
Biomedical Engineering and Biophysics, Clinical Research
View Dr. Pinto's PubMed Summary.

Selected Recent Publications

  1. Comparison of magnetic resonance imaging and ultrasound (MRI-US) fusion-guided prostate biopsies obtained from axial and sagittal approaches.
    Hong CW, Rais-Bahrami S, Walton-Diaz A, Shakir N, Su D, George AK, Merino MJ, Turkbey B, Choyke PL, Wood BJ, Pinto PA.
    BJU Int. 115: 772-9, 2015. [ Journal Article ]
  2. Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies.
    Rais-Bahrami S, Siddiqui MM, Vourganti S, Turkbey B, Rastinehad AR, Stamatakis L, Truong H, Walton-Diaz A, Hoang AN, Nix JW, Merino MJ, Wood BJ, Simon RM, Choyke PL, Pinto PA.
    BJU Int. 115: 381-8, 2015. [ Journal Article ]
  3. Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets.
    Farsaci B, Jochems C, Grenga I, Donahue RN, Tucker JA, Pinto PA, Merino MJ, Heery CR, Madan RA, Gulley JL, Schlom J.
    Int J Cancer. 135: 862-70, 2014. [ Journal Article ]
  4. Changes observed in multiparametric prostate magnetic resonance imaging characteristics correlate with histopathological development of chronic granulomatous prostatitis after intravesical Bacillus Calmette-Guerin therapy.
    Logan JK, Walton-Diaz A, Rais-Bahrami S, Merino MJ, Turkbey B, Choyke PL, Pinto PA.
    J Comput Assist Tomogr. 38: 274-6, 2014. [ Journal Article ]
  5. Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology.
    Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, Mena E, Daar D, Rastinehad AR, Linehan WM, Wood BJ, Pinto PA, Choyke PL.
    J Magn Reson Imaging. 39: 1443-8, 2014. [ Journal Article ]

Dr. Pinto is an Investigator and faculty member in the Urologic Oncology Branch of the National Cancer Institute, National Institutes of Health in Bethesda, Md. Following a residency in Urologic Surgery at Long Island Jewish Medical Center - Albert Einstein College of Medicine in New York, he was a Fellow and Clinical Instructor at the Brady Urologic Institute, Johns Hopkins Hospital. Dr. Pinto is a Board Certified Urologic Surgeon specializing in oncology and is the Director of the Urologic Oncology Fellowship Program at the National Cancer Institute. He is nationally and internationally recognized as an expert in the minimally invasive treatment of urologic cancers, specializing in laparoscopic and robotic surgery for prostate, kidney, bladder, and testicular cancer.

Name Position
Brian Calio MRSP Fellow
Julian Custer Research Biologist (Contr)
Linda Gaines Patient Care Coordinator (Contr)
Samuel Gold MRSP Fellow
Samuel Gold MRSP Fellow
Graham Hale MRSP Fellow
Hui Han M.S. Medical Writer
Nida Hussain Data Manager (Contr.)
Charlotte Payne R.N. Research Nurse (Contr)
Dordaneh Sugano MRSP Fellow
Maria Trattler N.P. Nurse Practitioner (Contr.)
Nana Yaqub-Ogun P.A. Physician Assistant
The JAMA Report: MRI/Ultrasound Fusion Biopsy for Prostate Cancer